Stock BVXP BIOVENTIX PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bioventix PLC

Equities

BVXP

GB00B4QVDF07

Biotechnology & Medical Research

Market Closed - London S.E.
Other stock markets
 11:35:15 2024-04-26 am EDT 		5-day change 1st Jan Change
4,450 GBX +0.56% Intraday chart for Bioventix PLC -3.26% +3.49%
Mar. 25 Bioventix ups dividend as profit rises; says headwinds temporary AN
Mar. 25 Bioventix plc Announces Interim Dividend, Payable on 26 April 2024 CI

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 192.3 216.1 206.8 179.7 201 232.3 - -
Enterprise Value (EV) 1 185.8 208 206.8 173.6 201 226.3 225.9 232.3
P/E ratio 33.4 x 30.1 x 31 x 23.6 x 24.3 x 27 x 25 x -
Yield 3.21% 3.4% - 3.65% - 3.62% 3.87% -
Capitalization / Revenue 20.7 x 21 x 18.9 x 15.3 x - 16.6 x 15.4 x -
EV / Revenue 20 x 20.2 x 18.9 x 14.8 x - 16.2 x 15 x -
EV / EBITDA 26.6 x 24.7 x - 18 x - 20 x 18.5 x 2.04 x
EV / FCF 32.1 x 28.3 x - 23 x - 26.6 x 25.1 x -
FCF Yield 3.12% 3.53% - 4.35% - 3.76% 3.98% -
Price to Book 17.8 x 17.3 x - 15.2 x - 18.4 x 17.2 x -
Nbr of stocks (in thousands) 5,143 5,208 5,209 5,209 5,220 5,220 - -
Reference price 2 37.40 41.50 39.70 34.50 38.50 44.50 44.50 44.50
Announcement Date 10/21/19 10/19/20 10/18/21 10/24/22 10/30/23 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 9.29 10.31 10.93 11.72 - 14 15.1 -
EBITDA 1 6.98 8.433 - 9.662 - 11.3 12.2 113.8
EBIT 1 6.913 8.299 - 9.274 - 11.2 12.1 -
Operating Margin 74.41% 80.47% - 79.13% - 80% 80.13% -
Earnings before Tax (EBT) 1 6.965 8.225 - 9.278 - 11.2 12.1 -
Net income 1 5.862 7.203 6.731 7.674 8.372 8.6 9.3 -
Net margin 63.1% 69.84% 61.58% 65.48% - 61.43% 61.59% -
EPS 2 1.121 1.379 1.279 1.459 1.583 1.646 1.779 -
Free Cash Flow 1 5.793 7.343 - 7.545 - 8.5 9 -
FCF margin 62.36% 71.2% - 64.38% - 60.71% 59.6% -
FCF Conversion (EBITDA) 82.99% 87.08% - 78.09% - 75.22% 73.77% -
FCF Conversion (Net income) 98.83% 101.95% - 98.32% - 98.84% 96.77% -
Dividend per Share 2 1.200 1.410 - 1.260 - 1.610 1.720 -
Announcement Date 10/21/19 10/19/20 10/18/21 10/24/22 10/30/23 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2024 S1 2024 S2
Net sales 1 - 7.326
EBITDA - -
EBIT 1 - 5.838
Operating Margin - 79.69%
Earnings before Tax (EBT) 1 - 5.917
Net income 4.024 -
Net margin - -
EPS 2 0.7596 0.8800
Dividend per Share 2 - 0.9300
Announcement Date 3/25/24 -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 6.54 8.08 - 6.13 - 6 6.4 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 5.79 7.34 - 7.55 - 8.5 9 -
ROE (net income / shareholders' equity) 53.5% 61.7% - 67% - 69.7% 70.4% -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 2.110 2.400 - 2.270 - 2.420 2.580 -
Cash Flow per Share - - - - - - - -
Capex 1 0.08 0.34 - 0.01 - 0.1 0.1 -
Capex / Sales 0.91% 3.29% - 0.1% - 0.71% 0.66% -
Announcement Date 10/21/19 10/19/20 10/18/21 10/24/22 10/30/23 - - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BIOVENTIX PLC Stock Bioventix PLC
+3.49% 289M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. BVXP Stock
  4. Financials Bioventix PLC